60 likes | 82 Views
The BCG vaccine market is estimated to reach $28,051 thousand by 2023, growing at a CAGR of 4.6% from 2017 to 2023. The Indian BCG vaccines market holds the highest share in the global BCG vaccines market.<br><br>Get sample copy: https://goo.gl/oHbpbY
E N D
BCG Vaccine Market by Demographics [Pediatrics (0-18 Years) and Adults (19-35 Years)] - Global Opportunity Analysis and Industry Forecast, 2017-2023 BCG Vaccine Market
BCG Vaccine Market Introduction Bacillus Calmette-Gurin (BCG) vaccine is the only vaccine currently available for prevention of tuberculosis (TB). One dose of BCG vaccine is recommended for healthy babies at birth in countries where tuberculosis is common.
BCG Vaccine Market Factors Contributing to Market Growth The major factor that contributes to the market growth are increase in incidence rate of tuberculosis in developing nations, rise in R&D activities related to vaccines, and growth in government initiatives and focus on immunization programs globally.
BCG Vaccine Market Market Segments
BCG Vaccine Market Leading Players The list of key players profiled in this report include Merck & Co., Inc., Sanofi Pasteur, Japan BCG Laboratory, China National Biotec Group (a subsidiary of China National Pharmaceutical Group Corporation), Serum Institute of India Pvt. Ltd., InterVax Ltd., GreenSignal Bio Pharma Limited (GSBPL), and Statens Serum Institut.
A report titled “BCG vaccine market- Opportunities and Forecasts, 2017 – 2023” has been recently published by Allied Market Research. It makes an in-depth analysis of current trends, drivers, and restraining factors that affect financial ratios relevant to the industry. Company profiles for key vendors in business builds a comprehensive picture of profitable opportunities from stakeholder’s perspective. To know more about the BCG vaccine market- Opportunities and Forecasts, 2017 – 2023 report: https://www.alliedmarketresearch.com/BCG-vaccine-market Follow us on Thank You